Vicarious Surgical Inc.RBOTNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-8.5%
5Y CAGR+28.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-8.5%/yr
Annual compound
5Y CAGR
+28.0%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
3.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$33.60M-16.3%
2024$40.16M-15.6%
2023$47.58M+8.4%
2022$43.90M+99.0%
2021$22.06M+125.2%
2020$9.80M+31.0%
2019$7.48M-